Table 3.
Maternal outcomes among different treatment.
| Pre. plus IVIg (n = 151) |
Pre. (n = 172) |
IVIg (n = 105) |
p value | |||
|---|---|---|---|---|---|---|
| IVIg versus Pre | Pre. plus IVIg versus IVIg | Pre. plus IVIg versus pre. | ||||
| Maternal response to initial treatment, (%) | 62 (41.1) | 57 (33.1) | 40 (38.1) | 0.960 | 0.634 | 0.550 |
| Maternal platelet count at delivery (×109/l), mean (SD) | 63.57 (41.06) | 67.61 (33.53) | 67.52 (34.59) | 0.984 | 0.337 | 0.265 |
| Antepartum hemorrhage, n (%) | 8 (5.3) | 5 (2.9) | 5 (4.8) | 0.458 | 0.834 | 0.288 |
| Postpartum hemorrhage, n (%) | 9 (6.0) | 6 (3.5) | 2 (1.9) | 0.481 | 0.079 | 0.222 |
| Pre-delivery platelet transfusion, n (%) | 11 (7.3) | 18 (10.5) | 15 (14.3) | 0.227 | 0.031 | 0.264 |
| Peripartum transfusion: any blood product, n (%) | 11 (7.3) | 23 (13.4) | 18 (17.1) | 0.262 | 0.004 | 0.045 |
| Hemoglobin drop > 30 g/l after delivery | 20 (13.2) | 12 (7.0) | 17 (16.2) | 0.014 | 0.442 | 0.063 |
IVIg, intravenous immunoglobulin; Pre., prednisone; SD, standard deviation.